Chembio Diagnostics, Inc. (CEMI) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Chembio Diagnostics, Inc. (CEMI) - Medical Equipment - Deals and Alliances Profile

Chembio Diagnostics, Inc. (CEMI) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Chembio Diagnostics, Inc. (CEMI) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
47 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Chembio Diagnostics, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products prevent the spread of infectious diseases with solutions like Chembio Dual Path Platform (DPP), which makes POC testing faster. Its DPP technology uses to treat infectious diseases such as HIV, Ebola, syphilis, malaria and febrile illness. The company offers its products to medical laboratories and hospitals, non-governmental organizations, governmental and public health entities, medical professionals and retailers. It also offers veterinary diagnostics.

Chembio Diagnostics, Inc. (CEMI) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent

  
Source:
Document ID
GDME1190D
Country
Industry
Ticker
CEMI=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Chembio Diagnostics, Inc., Medical Equipment, Deals By Year, 2010 to YTD 201652
Chembio Diagnostics, Inc., Medical Equipment Deals By Type, 2010 to YTD 201671
Chembio Diagnostics, Inc., Medical Equipment, Deals By Region, 2010 to YTD 201681
Chembio Diagnostics, Inc., Medical Equipment, Deals By Market, 2010 to YTD 201691
Chembio Diagnostics, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016101
Chembio Diagnostics, Inc., Medical Equipment, Deal Details1112
  Partnerships111
    Chembio Diagnostics Enters Into Licensing Agreement With RVR Diagnostics111
    Genisphere Enters Into Licensing Agreement With Chembio Diagnostics121
    Chembio Diagnostics Enters into Co-Development Agreement with Bio-Manguinhos131
    Chembio Diagnostics Enters into Agreement with Perseus Science141
    Chembio Diagnostics Enters into Co-Development Agreement with Integrated BioTherapeutics151
    Chembio Diagnostics Enters into Agreement to Develop POC Diagnostic Tests for Dengue Fever Virus and Specific Type of Cancer161
    Chembio Terminates Distribution Agreement With Alere171
    Chembio Enters Into Distribution Agreement With Labtest For Dual Path Platform Products181
    Chembio Diagnostic Enters Into Technology Transfer With Oswaldo Cruz Foundation191
  Equity Offering201
    Chembio Diagnostics Raises USD13.8 Million in Public Offering of Shares202
    Chembio Diagnostics Completes Public Offering Of Common Stock For US$6 Million221
Chembio Diagnostics, Inc. - Key Competitors231
Key Employees241
Locations And Subsidiaries251
  Head Office251
  Other Locations &Subsidiaries251
Recent Developments261
Financial Announcements261
Aug 11, 2016: Chembio Diagnostics Reports Second Quarter 2016 Financial Results263
Jul 25, 2016: Chembio Diagnostics Announces Preliminary Second Quarter 2016 Results291
May 12, 2016: Chembio Diagnostics Reports First Quarter 2016 Financial Results302
Mar 08, 2016: Chembio Diagnostics Reports 2015 Financial Results322
Nov 12, 2015: Chembio Diagnostics Reports Third Quarter Financial Results342
Aug 06, 2015: Chembio Diagnostics Reports Second Quarter Financial Results362
May 07, 2015: Chembio Diagnostics Reports First Quarter 2015 Financial Results382
Mar 05, 2015: Chembio Diagnostics Reports 2014 Financial Results402
Corporate Communications421
Oct 11, 2016: Chembio Expands Global Commercial Operations Leadership421
Product News431
Feb 09, 2015: Chembio's DPP HIV-Syphilis Assay Cleared for Launch in Brazil431
Jan 12, 2015: Chembio Update on DPP Ebola and DPP Febrile Illness Assays441
Other Significant Developments451
Sep 23, 2016: Chembio Expands Exclusive Distribution Agreements with Isla Lab to Include Puerto Rico and U.S. Virgin Islands451
Aug 25, 2016: Chembio Awarded Up to $13.2 Million U.S. Government Contract to Develop and Commercialize Point-of-Care Tests for Zika Virus461
Appendix471
  Methodology471
  About GlobalData471
  Contact Us471
  Disclaimer471

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Chembio Diagnostics, Inc. (CEMI) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Chembio-Diagnostics-Inc-CEMI-Medical-Equipment-Deals-and-Alliances-Profile-2148-5555>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Chembio Diagnostics, Inc. (CEMI) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Chembio-Diagnostics-Inc-CEMI-Medical-Equipment-Deals-and-Alliances-Profile-2148-5555>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research